Pharmaron

Sustainability Report and Carbon Intensity Rankings

Is Pharmaron doing their part?

Their DitchCarbon score is 45

Pharmaron has a DitchCarbon Score of 45 out of 100, indicating moderate performance in sustainability practices. This score reflects the company’s current carbon intensity, suggesting there is significant room for improvement in reducing emissions. A higher score would demonstrate a stronger commitment to lowering carbon intensity and enhancing overall environmental sustainability.

This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.

Industry emissions intensity

Very low

Low

Medium

High

Very high

Pharmaron is a company in the research and development sector, which has a very low carbon intensity ranking. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.

Location emissions intensity

Very low

Low

Unknown

High

Very high

Pharmaron, located in China, operates in a region with a certain carbon intensity rating. The sustainability of the company’s operations is influenced by China’s overall carbon intensity, affecting its environmental impact.

Unlock 30+ emissions intelligence data points

Get the emissions intelligence you need, no surveys required.

– Historical Scope 1, 2 and 3 emissions

– Coverage of all industries, product level data

– Emissions forecasting, assurances

Unlock 30+ emissions data points on Pharmaron

Get the emissions intelligence you need, no surveys required.

– Historical Scope 1, 2 and 3 emissions

– Coverage of all industries, product level data

– Emissions forecasting, assurances

6.36%

...this company is doing 6.36% worse in emissions than the industry average.

Pharmaron, founded in 2003 and headquartered in Beijing, operates in the research and development sector within the life science industry. The company boasts a global presence with facilities in China, the US, and the UK, employing over 5,000 professionals. Pharmaron offers a comprehensive range of R&D services, including synthetic and medicinal chemistry, biology, pharmacology, and clinical development, to partners across North America, Europe, Japan, and China.

Compare Pharmaron with other companies in the same industry –>

emission intelligence's platform recommendations for Pharmaron

Pharmaron should consider implementing green procurement policies to source low-carbon energy and services, which could potentially reduce their emissions by 30%.

Good news, Pharmaron has embraced SBTi commitments

Pharmaron has pledged to align its operations and strategies with the Science Based Targets initiative to significantly reduce greenhouse gas emissions. This commitment involves setting science-based emissions reduction targets consistent with keeping global warming below 2 degrees Celsius.

Participating

Claim this profile

Are you associate with this company?
Help us improve our data and claim this profile.

Our methodology

Read about our emission calculation methodologies, and what the DitchCarbon Score means.

Other company reports in this industry

Looking for a specific company?

Search our company directory or contact us for custom data requests.

Pharmaron

Sustainability Report and Carbon Intensity Rankings

Is Pharmaron doing their part?

Their DitchCarbon score is 45

Industry emissions intensity

Very low

Low

Medium

High

Very high

Location emissions intensity

Very low

Low

Unknown

High

Very high

Unlock 30+ emissions intelligence data points

Unlock 30+ emissions data points on Pharmaron

...this company is doing 6.36% worse in emissions than the industry average.

emission intelligence's platform recommendations for Pharmaron

Good news, Pharmaron has embraced SBTi commitments

Claim this profile

Our methodology

Other company reports in this industry

Looking for a specific company?

Quicklinks

Resources

Get in touch